GlassScriptPhysician profile
Eslam Elhammady
NPI 1336269174
$1,411.35
in general payments reported to CMS, 2019-2025
15 companies · $78.43 in 2025
The $78.43 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $935 · 2023: $56.94 · 2024: $341 · 2025: $78.43.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $476.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $475.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coloplast Corp | $964.37 | 2022-2025 | |
| Medical Device Business Services, INC. | $117.16 | 2024 | Stratafix |
| Dexcom, INC. | $68.91 | 2024 | Dexcom G6 Transmitter |
| Abiomed | $40.29 | 2024 | Impella |
| Otsuka America Pharmaceutical, INC. | $29.82 | 2024 | Rexulti |
| Merck Sharp & Dohme LLC | $28.47 | 2024 | Vaxneuvance, Gardasil, Capvaxive |
| Janssen Pharmaceuticals, INC | $24.38 | 2023 | Xarelto |
| Ethicon US, LLC | $21.03 | 2024 | Ethicon, Vistaseal, Dermabond |
| Aspira Women'S Health INC | $19.64 | 2024 | Ova1 |
| Viatris Specialty LLC | $19.55 | 2025 | Yupelri |
| Pfizer INC. | $16.52 | 2023 | |
| Cranial Technologies, INC | $16.04 | 2023 | Doc Band |
| Exact Sciences Corporation | $15.36 | 2025 | Cologuard Collection Kit |
| Astellas Pharma US INC | $15.24 | 2024 | Veozah |
| Vital Connect, INC | $14.57 | 2025 | Vitalpatch Rtm |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eslam Elhammady listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.